duloxetine 30 MG Delayed Release Oral Capsule
1 INDICATIONS AND USAGE Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive disorder in adults Generalized Anxiety disorder in adults and pediatric patients 7 years of age and older Diabetic peripheral neuropathic pain in adults Fibromyalgia in adults Chronic Musculoskeletal Pain in adults Additional pediatric use information is approved for Eli Lilly and Company, Inc.'s CYMBALTA (duloxetine) delayed-release capsules. However, due to Eli Lilly and Company Inc.'s marketing exclusivity rights, this drug product is not labeled with that pediatric information. Duloxetine is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of the following conditions: Major Depressive Disorder (MDD) in adults (1) Generalized Anxiety Disorder (GAD) in adults and pediatric patients 7 years of age and older (1) Diabetic Peripheral Neuropathic Pain (DPNP) in adults (1) Fibromyalgia (FM) in adults (1) Chronic Musculoskeletal Pain in adults (1)
Zydus Pharmaceuticals (USA) Inc.
CAPSULE BLUE 242 30mg
Related Pills
duloxetine 60 MG Delayed Release Oral Capsule
Zydus Pharmaceuticals (USA) Inc.
duloxetine 20 MG Delayed Release Oral Capsule
Zydus Pharmaceuticals (USA) Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
DULOXETINE Delayed-Release capsules, USP equivalent to 20 mg of
DULOXETINE are white to off-white free flowing pellets filled in size '4' hard gelatin capsules with green colored cap printed with "241" in golden ink and white body printed with "20 mg" in golden ink and are supplied as follows: NDC 68382-385-06 in bottle of 30 capsules with child-resistant closure NDC 68382-385-14 in bottle of 60 capsules with child-resistant closure NDC 68382-385-16 in bottle of 90 capsules with child-resistant closure
DULOXETINE Delayed-Release capsules, USP equivalent to 30 mg of
DULOXETINE are white to off-white free flowing pellets filled in size '3' hard gelatin capsules with blue-colored cap printed with "242" in golden ink and green-colored body printed with "30 mg" in golden ink and are supplied as follows: NDC 68382-386-06 in bottle of 30 capsules with child-resistant closure NDC 68382-386-16 in bottle of 90 capsules with child-resistant closure NDC 68382-386-10 in bottle of 1,000 capsules
DULOXETINE Delayed-Release capsules, USP equivalent to 60 mg of
DULOXETINE are white to off-white free flowing pellets filled in size '1' hard gelatin capsules with blue-colored cap printed with "243" in golden ink and white-colored body printed with "60 mg" in golden ink and are supplied as follows: NDC 68382-387-06 in bottle of 30 capsules with child-resistant closure NDC 68382-387-16 in bottle of 90 capsules with child-resistant closure NDC 68382-387-10 in bottle of 1,000 capsules 16.2 Storage and Handling Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight container.
More pills like CAPSULE 242 30mg